Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Grey Wolf Animal Health to Present at The 2023 Bloom Burton & Co. Healthcare Investor Conference

V.WOLF

Toronto, Ontario--(Newsfile Corp. - April 13, 2023) - Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, today announced that Angela Cechetto, CEO, is scheduled to present a corporate update at the 2023 Bloom Burton & Co. Healthcare Investor Conference on Tuesday April 25, 2023 at 2:30pm ET at the Metro Toronto Convention Centre in Toronto.

Grey Wolf management will also be available for one-on-one meetings during both days of the conference to be held on April 25-26, 2023. Investors interested in meeting with Grey Wolf during the conference should contact the conference coordinator or email investors@greywolfah.com.

About Grey Wolf Animal Health Corp.‎

Grey Wolf Animal Health Corp., headquartered in Toronto, Canada, is a diversified animal health ‎company founded by a veterinarian to bring to market a broad portfolio of products that meets the ‎unmet needs of veterinarians, clinics and pets. The Company's strategy is to in-license, acquire or develop innovative prescription and non-prescription products for commercialization in the veterinarian channel ‎in Canada. For additional information, please visit: www.greywolfah.com.‎

For further information, please contact:‎

Angela Cechetto
Chief Executive Officer
E-mail: investors@greywolfah.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Forward-Looking Statements

This news release includes certain statements that may be deemed "forward-looking statements." All statements in this new release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential," and similar expressions, or that events or conditions "will," "would," "may," "could," or "should" occur. Forward-looking information in this news release includes statements related to the Company's attendance at the 2023 Bloom Burton & Co. Healthcare Investor Conference. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/162275



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today